IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding IGC Pharma, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 29 | 32 | +3 |
| Shares | 4.81M | 5.34M | +526.7K (+11.0%) |
| Value | $7.90M | $7.90M | +$4.00K (+0.1%) |
New holders (6)
Institutions that held IGC Pharma, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | 404,526 | $599.0K | 0.00% |
| Vident Investment Advisory, LLC | 56,330 | $83.0K | 0.00% |
| Marshall Wace, LLP | 20,750 | $31.0K | 0.00% |
| Wolverine Trading, LLC | 13,294 | $20.0K | 0.00% |
| HRT Financial LP | 12,749 | $18.0K | 0.00% |
| Toronto Dominion Bank | 210 | $0 | 0.00% |
Sold out (3)
Institutions that held IGC Pharma, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Penserra Capital Management LLC | 56,068 | $98.0K |
| Price T Rowe Associates Inc | 43,000 | $71.0K |
| Squarepoint Ops LLC | 12,182 | $20.0K |